Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The pulmonary physician in critical care. Illustrative case 1: cystic fibrosis.

Literature DB >> 12668804

The pulmonary physician in critical care. Illustrative case 1: cystic fibrosis.

Abstract

The case history of a patient with CF admitted to an ICU is presented and the appropriateness of intensive care management for patients with CF is discussed. Issues relevant to the ICU care of patients with CF are highlighted.

Entities: Disease Species

Mesh：

Year: 2003 PMID： 12668804 PMCID： PMC1746651 DOI： 10.1136/thorax.58.4.357

Source DB: PubMed Journal: Thorax ISSN： 0040-6376 Impact factor: 9.139

25 in total

1. Bronchial arteriography and embolotherapy for hemoptysis in patients with cystic fibrosis.

Authors: I L Tonkin; A S Hanissian; T F Boulden; S L Baum; M L Gavant; R E Gold; P George; W J Green
Journal: Cardiovasc Intervent Radiol Date: 1991 Jul-Aug Impact factor: 2.740

2. Liver disease and bile duct abnormalities in adults with cystic fibrosis.

Authors: R A Nagel; D Westaby; A Javaid; J Kavani; H B Meire; M G Lombard; A Wise; R Williams; M E Hodson
Journal: Lancet Date: 1989-12-16 Impact factor: 79.321

3. Infarction of the left main-stem bronchus: a complication of bronchial artery embolization.

Authors: M J Ivanick; W Thorwarth; J Donohue; V Mandell; D Delany; P F Jaques
Journal: AJR Am J Roentgenol Date: 1983-09 Impact factor: 3.959

4. Treatment of recurrent severe hemoptysis in cystic fibrosis with tranexamic acid.

Authors: G R Graff
Journal: Respiration Date: 2001 Impact factor: 3.580

5. Once-daily tobramycin in the treatment of adult patients with cystic fibrosis.

Authors: A Whitehead; S P Conway; C Etherington; N A Caldwell; N Setchfield; S Bogle
Journal: Eur Respir J Date: 2002-02 Impact factor: 16.671

6. A meta-analysis of prospective trials comparing percutaneous and surgical tracheostomy in critically ill patients.

Authors: B D Freeman; K Isabella; N Lin; T G Buchman
Journal: Chest Date: 2000-11 Impact factor: 9.410

7. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.

Authors: V Master; G W Roberts; K P Coulthard; P A Baghurst; A Martin; M E Roberts; C R Onishko; A J Martin; R J Linke; M Holmes; A Jarvinen; D Kennedy; K A Colebatch; D Hansman; D W Parsons
Journal: Pediatr Pulmonol Date: 2001-05

8. Assisted ventilation for patients with cystic fibrosis.

Authors: P B Davis; P A di Sant'Agnese
Journal: JAMA Date: 1978-05-05 Impact factor: 56.272

9. Adverse reactions to piperacillin in adults with cystic fibrosis.

Authors: R J Stead; H G Kennedy; M E Hodson; J C Batten
Journal: Thorax Date: 1985-03 Impact factor: 9.139

10. Recombinant human DNase I in cystic fibrosis patients with severe pulmonary disease: a short-term, double-blind study followed by six months open-label treatment.

Authors: P I Shah; A Bush; G J Canny; A A Colin; H J Fuchs; D M Geddes; C A Johnson; M C Light; S F Scott; D E Tullis
Journal: Eur Respir J Date: 1995-06 Impact factor: 16.671

2 in total

1. Patients with cystic fibrosis should be intubated and ventilated.

Authors: Ian Ketchell
Journal: J R Soc Med Date: 2010-07 Impact factor: 5.344

2. Critical illness among adults with cystic fibrosis in Texas, 2004-2013: Patterns of ICU utilization, characteristics, and outcomes.

Authors: Lavi Oud
Journal: PLoS One Date: 2017-10-24 Impact factor: 3.240

2 in total